ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
0,00%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,575
-0,14%
Bitcoin
65 450,08
0,75%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Ampio Pharmaceuticals Inc (AMPE)

  7. Ampio Pharmaceuticals Inc (AMPE) Actualités

AMPE Ampio Pharmaceuticals Inc

0,62
0,00 (0,00%)
18 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Ampio Pharmaceuticals Inc AMPE AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,62 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,62 0,62
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/4/202420:33PRNUSAmpio Pharmaceuticals Received Audit Opinion with Going..
25/3/202422:00PRNUSAmpio Announces Voluntary Delisting and SEC Deregistration
05/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
28/2/202421:49EDGAR2Form 8-K - Current report
28/2/202421:48EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202421:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202421:46EDGAR2Form POS AM - Post-Effective amendments for registration..
28/2/202421:45EDGAR2Form RW - Registration Withdrawal Request
15/2/202415:31EDGAR2Form 8-K - Current report
14/2/202423:45PRNUSAmpio Provides Update on Results from Pre-IND Enabling..
25/1/202422:31EDGAR2Form 8-K - Current report
25/1/202422:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/1/202423:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202422:20EDGAR2Form 8-K - Current report
11/1/202422:15PRNUSAmpio Provides Litigation Update - Reports Settlement in..
21/12/202322:25EDGAR2Form S-1 - General form for registration of securities under..
14/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:30EDGAR2Form 8-K - Current report
31/10/202314:00PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
27/10/202320:10EDGAR2Form 8-K - Current report
06/10/202320:56EDGAR2Form 8-K - Current report
05/10/202322:30PRNUSAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO..
04/10/202322:15EDGAR2Form 8-K - Current report
26/9/202315:15PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
22/9/202322:30EDGAR2Form 8-K - Current report
18/9/202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
31/8/202322:19EDGAR2Form 8-K - Current report
31/8/202312:30PRNUSAmpio Pharmaceuticals Announces Reverse Stock Split
15/8/202322:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/7/202317:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/7/202322:37EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

AMEX
AMPE
Ampio Pharmaceuticals
TSXV
GTM.P
G2M Cap
EU
FR0010804765
Cmcicfctfrn29sep14 Bonds
BTRX
GRTUSD
Graph Token
LSE
84LE
Municplty 39
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés